Cargando…

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

BACKGROUND: HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jong, Wesley, Aerts, Joeri, Allard, Sabine, Brander, Christian, Buyze, Jozefien, Florence, Eric, van Gorp, Eric, Vanham, Guido, Leal, Lorna, Mothe, Beatriz, Thielemans, Kris, Plana, Montse, Garcia, Félipe, Gruters, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580477/ https://www.ncbi.nlm.nih.gov/pubmed/31208472 http://dx.doi.org/10.1186/s13063-019-3409-1

Ejemplares similares

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019)

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix †
por: de Jong, Wesley, et al.
Publicado: (2019)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
por: Leal, Lorna, et al.
Publicado: (2018)

Efficient Induction of Antigen-Specific CD8(+) T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles
por: D’haese, Sigrid, et al.
Publicado: (2022)

Increases in condomless chemsex associated with HIV acquisition in MSM but not heterosexuals attending a HIV testing center in Antwerp, Belgium
por: Kenyon, Chris, et al.
Publicado: (2018)

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells
por: Maenhout, Sarah K., et al.
Publicado: (2014)

Before I Was CEO
por: Vanham, Peter
Publicado: (2016)

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023)

HIV Prevalence by Race Co-Varies Closely with Concurrency and Number of Sex Partners in South Africa
por: Kenyon, Chris, et al.
Publicado: (2013)

Antimicrobial Consumption and Susceptibility of Neisseria gonorrhoeae: A Global Ecological Analysis
por: Kenyon, Chris, et al.
Publicado: (2018)

The Prevalence of HIV by Ethnic Group Is Correlated with HSV-2 and Syphilis Prevalence in Kenya, South Africa, the United Kingdom, and the United States
por: Kenyon, Chris Richard, et al.
Publicado: (2014)

Strong association between higher-risk sex and HIV prevalence at the regional level: an ecological study of 27 sub-Saharan African countries
por: Kenyon, Chris R., et al.
Publicado: (2018)

Female Genital Cutting and Hepatitis C Spread in Egypt
por: Kenyon, Chris, et al.
Publicado: (2013)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
por: Hemachandra, A, et al.
Publicado: (2009)

Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
por: Kee, Hae Jin, et al.
Publicado: (2011)

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
por: Porter, David W., et al.
Publicado: (2011)

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
por: Joe, Patrick Tjok, et al.
Publicado: (2019)

Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia
por: Buyze, Jozefien, et al.
Publicado: (2020)

Small steps forward for HIV vaccine development
por: Mothe, Beatriz, et al.
Publicado: (2020)

Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa
por: Villadiego-Sánchez, J.M., et al.
Publicado: (2009)

A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee
por: Matsushita, Takehiko, et al.
Publicado: (2022)

Factors influencing social self-disclosure among adolescents living with HIV in Eastern Africa
por: Nöstlinger, Christiana, et al.
Publicado: (2015)

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
por: Lesueur, Paul, et al.
Publicado: (2019)

Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
por: Bialkowski, Lukasz, et al.
Publicado: (2016)

Nanoparticulate CpG Immunotherapy in RAO‐Affected Horses: Phase I and IIa Study
por: Klier, J., et al.
Publicado: (2015)

Metabolism of Tanshinone IIA, Cryptotanshinone and Tanshinone I from Radix Salvia Miltiorrhiza in Zebrafish
por: Wei, Yingjie, et al.
Publicado: (2012)

Diagnosis-to-surgery interval and survival for different histologies of stage I–IIA lung cancer
por: Zhang, Lu, et al.
Publicado: (2021)

A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa
por: Jespers, Vicky, et al.
Publicado: (2017)

P18-03. Dendritic cell-based immune therapy against HIV-1
por: Gruters, RA, et al.
Publicado: (2009)

Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
por: Roemhild, Andy, et al.
Publicado: (2020)

Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription
por: Pannus, Pieter, et al.
Publicado: (2020)

Structure–Function Relations of the First and Fourth Predicted Extracellular Linkers of the Type IIa Na(+)/P(i) Cotransporter: I. Cysteine Scanning Mutagenesis
por: Ehnes, Colin, et al.
Publicado: (2004)

Prognostic factors for mortality among patients with visceral leishmaniasis in East Africa: Systematic review and meta-analysis
por: Abongomera, Charles, et al.
Publicado: (2020)

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance
por: Takahashi, Yusuke, et al.
Publicado: (2018)

Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer
por: Ratosa, Ivica, et al.
Publicado: (2021)

Impact of different therapies on the survival of patients with stage I–IIA cervical cancer with intermediate risk factors
por: Nie, Jichan, et al.
Publicado: (2021)

Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial
por: Matsumoto, Takuya, et al.
Publicado: (2022)

Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer
por: Woo, Hyeok Sang, et al.
Publicado: (2022)

A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat
por: Vormfelde, Stefan Viktor, et al.
Publicado: (2020)

A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non–Small Cell Lung Cancer
por: Kim, Eo Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6oc9k57jm2u1dsckukdikm1b0d